{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:50:18Z","timestamp":1772794218530,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1136\/ard.62.4.350","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T00:01:21Z","timestamp":1047513681000},"page":"350-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service"],"prefix":"10.1016","volume":"62","author":[{"given":"I W","family":"Chantler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M W J","family":"Davie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S F","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.4.350_bib1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.62.4.350_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.62.4.350_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.62.4.350_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.62.4.350_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1136\/ard.62.4.350_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/thorax.56.4.279","article-title":"Adverse effects of oral corticosteroids in relation to dose in patients with lung disease","volume":"56","author":"Walsh","year":"2001","journal-title":"Thorax"},{"key":"10.1136\/ard.62.4.350_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"Q J Med"},{"key":"10.1136\/ard.62.4.350_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.1995.tb00868.x","article-title":"Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis","volume":"237","author":"Eastell","year":"1995","journal-title":"J Intern Med"},{"key":"10.1136\/ard.62.4.350_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1136\/ard.62.4.350_bib10","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.4.350_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbmr.5650070909","article-title":"Estrogen and progesterone replacement therapy reduces corticosteroid-induced bone loss","volume":"7","author":"Lukert","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.62.4.350_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.54.1.49","article-title":"Rheumatoid arthritis, corticosteroid therapy and hip fracture","volume":"54","author":"Cooper","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.62.4.350_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thx.46.11.803","article-title":"Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study","volume":"46","author":"Luengo","year":"1991","journal-title":"Thorax"},{"key":"10.1136\/ard.62.4.350_bib14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1359\/jbmr.2000.15.5.952","article-title":"Corticosteroids do not alter the threshold for vertebral fracture","volume":"15","author":"Selby","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.62.4.350_bib15","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724090459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724090459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.4.350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:26:25Z","timestamp":1737437185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724090459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0003496724090459"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.4.350","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.4.350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}